---
title: "Psych News Alert: Intravenous Ketamine May Be Effective in Treating Chronic PTSD, Preliminary Study Suggests"
description: Intravenous ketamine appears to produce rapid reduction in symptom severity in patients with chronic PTSD, according to the report of a “pro...
image: https://alert.psychnews.org/hubfs/Imported_Blog_Media/feder_2014-Jun-24-2025-03-51-35-8567-PM.jpg
---

 6/24/24 11:16 AM

# Intravenous Ketamine May Be Effective in Treating Chronic PTSD, Preliminary Study Suggests

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [ Psychiatric News Alert ](https://alert.psychnews.org/author/psychiatric-news-alert)

Share: [facebook-f icon ](http://www.facebook.com/share.php?u=https://alert.psychnews.org/2014/04/intravenous-ketamine-may-be-effective.html) [linkedin-in icon ](http://www.linkedin.com/shareArticle?mini=true&url=https://alert.psychnews.org/2014/04/intravenous-ketamine-may-be-effective.html) [Twitter icon ](https://twitter.com/intent/tweet?url=https://alert.psychnews.org/2014/04/intravenous-ketamine-may-be-effective.html) [pinterest-p icon ](http://pinterest.com/pin/create/link/?url=https://alert.psychnews.org/2014/04/intravenous-ketamine-may-be-effective.html) [envelope icon ](mailto:?body=https://alert.psychnews.org/2014/04/intravenous-ketamine-may-be-effective.html)

| ![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/feder_2014-Jun-24-2025-03-51-34-9156-PM.jpg?width=200&height=163&name=feder_2014-Jun-24-2025-03-51-34-9156-PM.jpg) |  |
| --- | --- |

Intravenous ketamine appears to produce rapid reduction in symptom severity in patients with chronic PTSD, according to the report of a “proof-of-concept” [study](https://archpsyc.jamanetwork.com/article.aspx?articleid=1860851) reported online in *JAMA Psychiatry*. The findings need to be replicated and extended, but could lead to novel pharmacologic treatments of this condition if results are replicated.

Researchers at the Icahn School of Medicine at Mount Sinai conducted a proof-of-concept randomized, double-blind, crossover trial comparing ketamine with an active placebo control, midazolam. Subjects received intravenous infusion of ketamine or midazolam. The primary outcome measure was change in PTSD symptom severity, measured with the Impact of Event Scale–Revised. Secondary outcome measures included the Montgomery-Asberg Depression Rating Scale, the Clinical Global Impression-Severity and Clinical Global Impression–Improvement scales, and adverse-effect measures.

Ketamine infusion was associated with significant and rapid reduction in PTSD symptom severity, compared with midazolam, when assessed 24 hours after infusion. It was also associated with reduction in comorbid depressive symptoms and improvement in overall clinical presentation. Ketamine was generally well tolerated.

Lead author Adriana Feder, M.D., told *Psychiatric News* that the study is the first proof-of-concept, randomized clinical trial of a single intravenous dose of ketamine for patients with chronic PTSD, compared to a single intravenous dose of midazolam. Since it is a proof-of-concept study, however, she said that "longer-term clinical trials will be necessary to determine whether ketamine will be a useful treatment for PTSD in clinical practice. To date, few pharmacotherapies have been shown to be sufficiently effective in the treatment of PTSD. These findings may lead to novel approaches in the treatment of this condition.” Feder noted that she and the study's principal investigator, Dennis Charney, M.D., have been named as inventors on a patent application covering use of ketamine for PTSD treatment. The study was funded by a grant from the Department of the Army-U.S. Navy Medical Researcher Acquisition Activity.

To read about research on other possible uses of ketamine in treating mental illness, see the *Psychiatric News* article, "[Ketamine Outperforms ECT in Depression Study](http://psychnews.psychiatryonline.org/newsarticle.aspx?articleid=1815058)."

(Image: Andrii Kondiuk/shutterstock.com)

[ketamine](https://alert.psychnews.org/tag/ketamine), [PTSD](https://alert.psychnews.org/tag/ptsd), [JAMA Psychiatry](https://alert.psychnews.org/tag/jama-psychiatry)

## Related posts

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/emergency_iStock_000058321222_Small-Jun-24-2025-03-45-06-6120-PM.jpg?height=200&name=emergency_iStock_000058321222_Small-Jun-24-2025-03-45-06-6120-PM.jpg) ](https://alert.psychnews.org/2019/11/ketamine-found-to-rapidly-reduce.html)

[suicide](https://alert.psychnews.org/tag/suicide), [ketamine](https://alert.psychnews.org/tag/ketamine), [depression](https://alert.psychnews.org/tag/depression), [blood pressure](https://alert.psychnews.org/tag/blood-pressure), [emergency department](https://alert.psychnews.org/tag/emergency-department), [dissociative effects](https://alert.psychnews.org/tag/dissociative-effects), [Yoav Domany](https://alert.psychnews.org/tag/yoav-domany)

## [Ketamine Found to Rapidly Reduce Suicidal Thoughts in Depressed, Suicidal Patients in ER](https://alert.psychnews.org/2019/11/ketamine-found-to-rapidly-reduce.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 6/24/24 11:16 AM

Patients presenting to an emergency room with complaints of suicidal thoughts may experience relief...

[ Read more ](https://alert.psychnews.org/2019/11/ketamine-found-to-rapidly-reduce.html)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/IV%20drip_iStock_00002009034-Jun-24-2025-03-52-30-1371-PM.jpg?height=200&name=IV%20drip_iStock_00002009034-Jun-24-2025-03-52-30-1371-PM.jpg) ](https://alert.psychnews.org/2016/05/ketamine-may-reduce-active-suicidal.html)

[suicide](https://alert.psychnews.org/tag/suicide), [ketamine](https://alert.psychnews.org/tag/ketamine), [depression](https://alert.psychnews.org/tag/depression), [suicidal ideation](https://alert.psychnews.org/tag/suicidal-ideation), [depression treatment](https://alert.psychnews.org/tag/depression-treatment)

## [Ketamine May Reduce Active Suicidal Thoughts in Patients With Treatment-Resistant Depression](https://alert.psychnews.org/2016/05/ketamine-may-reduce-active-suicidal.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 6/24/24 11:16 AM

Ketamine may be able to rapidly reduce persistent suicidal thoughts in medicated patients with...

[ Read more ](https://alert.psychnews.org/2016/05/ketamine-may-reduce-active-suicidal.html)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/doctor_patient_iStock-489555346-Jun-24-2025-03-48-58-0375-PM.jpg?height=200&name=doctor_patient_iStock-489555346-Jun-24-2025-03-48-58-0375-PM.jpg) ](https://alert.psychnews.org/2018/03/maintenance-ketamine-may-offer.html)

[ketamine](https://alert.psychnews.org/tag/ketamine), [anxiety](https://alert.psychnews.org/tag/anxiety), [generalized anxiety disorder](https://alert.psychnews.org/tag/generalized-anxiety-disorder), [Social anxiety disorder](https://alert.psychnews.org/tag/social-anxiety-disorder), [subcutaneous injection](https://alert.psychnews.org/tag/subcutaneous-injection), [maintenance treatment](https://alert.psychnews.org/tag/maintenance-treatment), [Paul Glue](https://alert.psychnews.org/tag/paul-glue)

## [Maintenance Ketamine May Offer Alternative for Patients With Treatment-Refractory Anxiety Disorders](https://alert.psychnews.org/2018/03/maintenance-ketamine-may-offer.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 6/24/24 11:16 AM

A small, open-label study of patients with treatment-refractory anxiety found that most patients...

[ Read more ](https://alert.psychnews.org/2018/03/maintenance-ketamine-may-offer.html)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Psychiatric News Alert",
    "url" : "https://alert.psychnews.org/author/psychiatric-news-alert"
  },
  "dateModified" : "2025-06-24T15:56:51.046Z",
  "datePublished" : "2024-06-24T15:16:15.000Z",
  "headline" : "Psych News Alert: Intravenous Ketamine May Be Effective in Treating Chronic PTSD, Preliminary Study Suggests",
  "image" : [ "https://alert.psychnews.org/hubfs/Imported_Blog_Media/feder_2014-Jun-24-2025-03-51-35-8567-PM.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://alert.psychnews.org/2014/04/intravenous-ketamine-may-be-effective.html",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://alert.psychnews.org/hubfs/PN-Blue-Box.jpg"
    }
  }
}
```